Significance of Plasma and Intragiomerular Thrombomodulin in Lupus Nephritis with Vascular Lesion

李世军,刘志红,陈书芬,曾彩虹,黎磊石
DOI: https://doi.org/10.3969/j.issn.1006-298x.2003.04.007
2003-01-01
Abstract:Objective:To study the significance of plasma soluble thrombomodulin (sTM) and intraglomerular thrombomodulin in patients with lupus nephritis (LN), and to explore the relationship between the sTM and disease activity, histological changes and vascular lesions as well as proteinuria. Methodology:Sixty patients with LN were divided into three groups according to the histological lesions. They were type Ⅱ of LN (LNⅡ, n=20), type Ⅳ (LNⅣ,n=20) and type Ⅳ with thrombotic microangiopathy (LN-TMA, n=20). Their plasma sTM were determined by enzyme-linked immunosorbent assay (ELISA), intraglomerular of thrombomodulin were examined by indirect immmunofluorescence. Results:The plasma levels of sTM in patients with type Ⅳ of LN were significantly higher than those in type Ⅱ LN patients, and normal controls. In patients with LN-TMA, their plasma levels of sTM were significantly increased compared with those LN-ⅣV patients without renal vascular lesions. A strong positive correlation was found between sTM and SLE Disease Activity Measurement Index (SLEDAI) or renal function. In patients with LN-Ⅱ, only very weak staining of TM was found on glomeruli, however, positive to strongly positive staining of TM was observed mainly along the capillary wall of glomeruli, interlobular arteries and peritubular capillaries in patients with LN-Ⅳ and LN-TMA. Conclusion:There are relationships among the degree of TM staining in the glomeruli, the histological patterns, and vascular lesions in patients with lupus nephritis. The level of plasma soluble thrombomodulin may be used as a marker of the SLE disease activity and severity of renal vascular injury in lupus nephritis.
What problem does this paper attempt to address?